Evidence mapPaperPMID 40569678Full record

ArticleThe Journal of clinical investigation2025

Dynamics of Th1/Th17 responses and antimicrobial pathways in leprosy skin lesions.

Priscila R Andrade, Feiyang Ma, Jing Lu, Jaime de Anda, Ernest Y Lee, George W Agak, Craig J Dobry, Bruno J de Andrade Silva, Rosane Mb Teles, Lilah A Mansky and 8 more

Abstract readClinical Study
In one paragraph

Article in The Journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Priscila R AndradeDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Feiyang MaDepartment of Molecular, Cell, and Developmental Biology and.
Jing LuDepartment of Molecular, Cell, and Developmental Biology and.
Jaime de AndaDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Ernest Y LeeDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
George W AgakDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Craig J DobryDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
Bruno J de Andrade SilvaDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Rosane Mb TelesDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Lilah A ManskyDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Jonathan PerrieDepartment of Molecular, Cell, and Developmental Biology and.
Dennis J MontoyaDepartment of Molecular, Cell, and Developmental Biology and.
Bryan D BrysonBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Johann E GudjonssonDepartment of Dermatology, University of Michigan, Ann Arbor, Michigan, USA.
Gerard Cl WongDepartment of Bioengineering, UCLA, Los Angeles, California, USA.
Euzenir N SarnoLeprosy Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Matteo PellegriniDepartment of Molecular, Cell, and Developmental Biology and.
Robert L ModlinDivision of Dermatology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.

Funding

Molecular analysis of host immune responses in leprosyR01AI022553 · UNIVERSITY OF SOUTHERN CALIFORNIA · 1989 to 2025
$3.3M
TCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · UNIVERSITY OF SOUTHERN CALIFORNIA · 1990 to 2025
$2.1M
Microbiology and Metagenomics CoreP50AR080594 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$1.4M
Dynamics of the cellular and molecular architecture of human pulmonary TB granulomasR01AI166313 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2024 to 2025
$1.3M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2024 to 2025
$1.2M
Cathelicidins in Skin ImmunityR01AI052453 · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · 2002 to 2005
$1.1M
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgarisR01AR081337 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$382k
Cellular and molecular architecture of granulomas in human tuberculous lymphadenitisR01AI169526 · INSTITUT PASTEUR DE TUNIS · 2025 to 2025
$145k
NIAID NIH HHS R01 AI022553NIAID NIH HHS R01 AI052453NIAID NIH HHS R01 AI166313NIAID NIH HHS R01 AI169526NIAID NIH HHS R37 AI052453NIAMS NIH HHS P50 AR080594NIAMS NIH HHS R01 AR040312NIAMS NIH HHS R01 AR073252NIAMS NIH HHS R01 AR081337
6 · The paper itself

Abstract

BACKGROUNDReversal reactions (RRs) in leprosy are acute immune episodes marked by inflammation and bacterial clearance, offering a model to study the dynamics of host responses to Mycobacterium leprae. These episodes are often severe and difficult to treat, frequently progressing to permanent disabilities. We aimed to characterize the immune mechanisms and identify antimicrobial effectors during RRs.METHODSWe performed RNA-Seq on paired skin biopsy specimens collected from 9 patients with leprosy before and at RR diagnosis, followed by differential gene expression and functional analysis. A machine-learning classifier was applied to predict membrane-permeabilizing proteins. Antimicrobial activity was assessed in M. leprae-infected macrophages and axenic cultures.RESULTSIn the paired pre-RR and RR biopsy specimens, a 64-gene antimicrobial response signature was upregulated during RR and correlated with reduced M. leprae burden. Predicted upstream regulators included IL-1β, TNF, IFN-γ, and IL-17, indicating activation of both the Th1 and Th17 pathways. A machine-learning classifier identified 28 genes with predicted membrane-permeabilizing antimicrobial activity, including S100A8. Four proteins (S100A7, S100A8, CCL17, and CCL19) demonstrated antimicrobial activity against M. leprae in vitro. Scanning electron microscopy revealed membrane damage in bacteria exposed to these proteins.CONCLUSIONRR is associated with a robust antimicrobial gene program regulated by Th1 and Th17 cytokines. We identified potentially novel host antimicrobial effectors that showed activity against M. leprae, suggesting potential strategies to bolster Th1 and Th17 responses for combating intracellular mycobacterial infections.FUNDINGNIH grants R01 AI022553, R01 AR040312, R01 AR073252, R01 AI166313, R01 AI169526, P50 AR080594, and 4R37 AI052453-21 and National Science Foundation (NSF) grant DMR2325840.

Indexed as

LeprosyMycobacterium lepraeSkinTh17 CellsTh1 CellsAdultFemaleHumansMachine LearningMaleMiddle AgedAdaptive immunityBacterial infectionsImmunologyInfectious diseaseInnate immunity

Identifiers

PMID40569678
PMCPMC12404764

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.